INTRODUCTION
============

Spermine, a low-molecular weight aliphatic biogenic amine naturally present in colostrum and milk, can contribute to synthesizing proteins and nucleic acids, modulating ion channel functions and calcium-related signal transduction, controlling cell membrane transport and metabolic processes, and increasing cell growth and proliferation \[[@b1-ajas-31-8-1325]--[@b5-ajas-31-8-1325]\]. Previous studies have shown that spermine plays an important role in regulating cell cycle progression of yeast during the oxidative stress response \[[@b6-ajas-31-8-1325]\]. A scientific report has indicated that spermine also has protective effects against B cell antigen receptor-mediated apoptosis through up-regulating Bcl-2 gene expression and down-regulating caspase mRNA abundance in rats \[[@b7-ajas-31-8-1325]\]. The physiology of pigs is more similar to that of humans than are rats \[[@b1-ajas-31-8-1325],[@b8-ajas-31-8-1325]\]. However, no information is available on the effects of spermine administration on the apoptosis of immune organs in piglets. Additionally, the precursor of spermine (i.e., arginine) can enhance amino acid absorption in the gut of piglets by up-regulating amino acid transporters, such as SLC7A7 and SLC7A1 \[[@b9-ajas-31-8-1325]\]. Nevertheless, the relationship between spermine supplementation and amino acid absorption of the thymus and spleen remains largely unknown. As such, further study is important and necessary.

This study is a part of the series investigation about the effects of spermine supplementation on immune function and antioxidant status in the thymus and spleen of piglets \[[@b3-ajas-31-8-1325]\]. Our objective was mainly to determine the effects of spermine supplementation on cell cycle, apoptosis, and amino acid transporters in the thymus and spleen of early weaned piglets. Here, representative gene expressions of the fields considered were assessed. Our findings may be potentially valuable for a better formula for piglets unable to be nursed by sow or even an ideal animal model for infants unable to be breastfed, providing scientific evidence for relieving weaning-related problems in livestock production.

MATERIALS AND METHODS
=====================

Animal care and feeding
-----------------------

The experimental procedures of this study was executed according to the actual law of animal protection (SYXK2014-187) and the Animal Care and Use Committee of Sichuan Agricultural University, and obeyed the established guidelines confirmed by Laboratory Animals of the National Research Council for animal welfare and use. The basic formula milk used in the current study was made from 1 kg of formula milk (dry matter 87.5%) and 4 L of drinking water to form the milk solution, and its nutritional levels met nutrient requirements for nursery piglets recommended by the National Research Council \[[@b10-ajas-31-8-1325]\], which is presented in [Table 1](#t1-ajas-31-8-1325){ref-type="table"} and the same as in our previous study \[[@b3-ajas-31-8-1325]\]. Ten healthy multiparous sows provided eighty 9 d old female piglets (Duroc×Landrace×Yorkshire) purchased from Pig Improvement Company. Afterward, they were acclimatized to the trial environment for 2 d before the experiment was started. Thus, they were 12 d old with body weight (BW) of 3.3 kg (standard error 0.03) when the experiment commenced, and the piglets were randomly allotted into eight groups (n = 10 per group). All the piglets were housed individually in stainless-steel wire-bottomed metabolism cages at the Animal Nutrition Institute, Sichuan Agricultural University. The piglets were placed under spot heat lamps and bottle-fed with milk-based diet every 3 h between 06:00 and 24:00 daily. The match-restricted intake was used in the current study. Namely, the spermine-supplemented piglets obtained nutrient intake with spermine (0.4 mmol/kg BW/24 h; dissolved in normal saline) in formula milk *ad libitum* for 7 h or 3, 6, or 9 d (Groups SP-7 h, SP-3 d, SP-6 d, and SP-9 d, respectively), and matched control piglets received the same formula milk given to the spermine-treated piglets with physiological saline (0.9% NaCl) once a day for 7 h or 3, 6, or 9 d (Groups Con-7 h, Con-3 d, Con-6 d, and Con-9 d, respectively). The piglets had free access to drinking water provided by water nipples. The ambient temperature and relative humidity of the room were kept at approximately 30°C and 50% to 60%, respectively. Spermine dosage and spermine-administration time employed in this experiment were selected based on a previous study \[[@b11-ajas-31-8-1325]\].

Tissue sample collection
------------------------

At the termination of 7 h, 3 d, 6 d, and 9 d feeding trails (at this time, the piglets were 12, 15, 18, and 21 d old, respectively), all the piglets were anesthetized with an intravenous injection of pentobarbital sodium (15 mg/kg BW), and sacrificed by exsanguination for thymus and spleen samples. The thymus and spleen of all piglets were quickly procured and washed with ice-cold normal saline (0.9% NaCl; 4°C), snap frozen in liquid nitrogen, and then preserved at −80°C for further real time-polymerase chain reaction (RT-PCR) analysis.

Total RNA extraction
--------------------

The total RNA of the thymus and spleen was extracted as previously described \[[@b3-ajas-31-8-1325]\]. Approximately 0.1 g of the frozen thymus or spleen tissues was promptly placed in prepared mortars and ground in liquid nitrogen. To remove excrescent samples, the powder was homogenized in 1 mL TRIzol reagent (Takara, Dalian, China) and centrifuged at 12,000×g for 10 min at 4°C until the samples were adequately dissolved, and the supernatant was obtained. The 200 μL trichloromethane was added to the supernatant, and the mixture was agitated for 20 s. After standing for 5 min, the mixture was centrifuged at 12,000×g for 15 min at 4°C, and 500 μL of supernatant (on the white band) was collected. Afterward, equal volumes of isopropyl alcohol (500 μL) were added to 500 μL of the supernatant, and the mixtures were slightly overturned for 5 s to mix the compound; the compound was centrifuged at 12,000×g for 10 min at 4°C after standing for 10 min. Following this process, the supernatant was discarded, and the precipitate was retained; 1 mL of 75% ethyl alcohol was added to the precipitate to scour the residual isopropyl alcohol and then centrifuged at 12,000×g for 5 min at 4°C. Next, 75% ethyl alcohol was removed, and the mixture was evaporated for 2 to 3 min; then, about 40 μL sterile water was added to dissolve the RNA precipitate. Aliquots of 4 μg RNA samples were used to detect their integrity by agarose gel electrophoresis (1%). Moreover, RNA concentration and quality were examined by Nano Drop 2000/2000C spectrophotometric analysis (Thermo Fisher Scientific, Wilmington, DE, USA) at 260 and 280 nm. The ratios of absorption (260/280 nm) of all samples were maintained at 1.8 to 2.0.

Synthesis of cDNA and real-time fluorescent quantitative PCR determination
--------------------------------------------------------------------------

For each sample, 1 μg of total RNA sample was used to synthesize cDNA by real-time RT-PCR according to the instructions of the commercial reverse transcription kit with gDNA Eraser (Takara, China). The cDNA was preserved at −20°C for relative fluorescent quantitative PCR assay. Based on the pig sequence, primers of the corresponding genes were designed by the Primer Express Software (version 3.0; Applied Biosystems, Foster City, CA, USA) and synthesized by TaKaRa Biotechnology Company (Takara, China), as shown in [Table 1](#t1-ajas-31-8-1325){ref-type="table"}. The reaction of real-time PCR for quantification was performed by a real-time PCR system (ABI 7900HT, Applied Biosystems, USA) according to the instructions of the SYBR Green I PCR reagent kit. The mixture (8 μL) of real-time fluorescent quantitative PCR was supplied as follows: SYBR Premix Ex Taq II with ROX Reference Dye (4 μL), cDNA (0.8 μL), 10 μM of forward primer (0.8 μL) and reverse primer (0.8 μL), and ddH2O (1.6 μL). The thermal cycler conditions for PCR included the following: denaturation (95°C for 10 s), 42 cycles (95°C for 10 s; annealing temperature \[[Table 2](#t2-ajas-31-8-1325){ref-type="table"}\] for 35 s), and extension step (72°C for 15 s). In this study, the housekeeping gene (β-actin) was employed as the reference gene transcript to normalize the expression levels of the other target genes. The relative expression quantity of the target genes was calculated according to the threshold cycle number as described in a previous study \[[@b12-ajas-31-8-1325]\]. The relative mRNA expression results of the target genes were analyzed according to the 2^−ΔΔCt^ method as described previously \[[@b13-ajas-31-8-1325]\] and were represented as their ratios to β-actin mRNA. Therefore, relative expression of target genes in C-7 served as 1 fold in the current experiment.

Statistical analysis
--------------------

All obtained results were expressed as means±standard error of the mean and statistically subjected to two-way analysis of variance (ANOVA) followed by Duncan's multiple range to separate statistical differences among the treatment groups, and determined for normality and homogeneity of variances using Shapiro--Wilk's W-test and Levene's test, respectively. The main effects in our experimental model involved spermine level (0 or 0.4 mmol/kg BW/24 h), treatment time (7 h, 3 d, 6 d, or 9 d) and interactions. The p-values \<0.05 were applied to statistical differences. Correlations among cell cycle, apoptosis and amino acid transporters were completed by Pearson correlation analysis. All statistical analyses were achieved using the general linear model procedure of SPSS 21.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

Cell cycle-related genes expression in the thymus and spleen
------------------------------------------------------------

The mRNA levels of cell cycle-related genes in the thymus are illustrated in [Figure 1](#f1-ajas-31-8-1325){ref-type="fig"}. Spermine ingestion significantly increased the gene expressions of cyclin A2 (Group SP-3 d vs Group Con-3 d; Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d) but markedly decreased mRNA expressions of p21 (Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d), cyclin D3 (Group SP-6 d vs Group Con-6 d), and cyclin E2 (Group SP-6 d vs Group Con-6 d; p\<0.05). Moreover, cyclin A2 gene expression was significantly improved with prolonged spermine supplementation (6 d), and then it decreased afterward (p\<0.05). The mRNA expression of p21 was lower at 6 d of spermine intake compared with those observed at 7 h, 3 d, or 9 d of spermine ingestion (p\<0.05). Cyclin D3 mRNA level was the highest in piglets that received spermine for 7 h and 3 d followed by those with 9 d of spermine intake, and the lowest was observed in piglets fed with spermine supplementation for 6 d (p\<0.05). Gene expression of cyclin E2 was markedly reduced after 6 d of spermine administration (p\<0.05), which plateaued thereafter.

As shown in [Figure 2](#f2-ajas-31-8-1325){ref-type="fig"}, in the spleen, gene expression of cyclin A2 (Group SP-3 d vs Group Con-3 d; Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d) significantly increased but p21 (Group SP-3 d relative to Group Con-3 d) and cyclin D3 (Group SP-9 d relative to Group Con-9 d) markedly decreased (p\<0.05), and no significant difference was found in cyclin E2 mRNA abundance that was induced by spermine intake (p\>0.05). In addition, cyclin A2 mRNA level was significantly enhanced with extended spermine supplementation of up to 6 d, and a decrease was observed afterward (p\<0.05). Expression of p21 gene decreased with the extension of spermine administration to up to 6 d (p\<0.05), and no marked differences were observed with further extension of spermine ingestion (p\>0.05). Cyclin D3 mRNA expression was maximum in the piglets supplemented with spermine for 7 h, and the minimum expression was observed after 6 d of spermine ingestion (p\<0.05).

Alterations of apoptosis-related genes expression in the thymus and spleen
--------------------------------------------------------------------------

[Figure 3](#f3-ajas-31-8-1325){ref-type="fig"} shows that spermine administration promoted a reduction in Bax (Group SP-3 d vs Group Con-3 d) and caspase-3 (Group SP-3 d vs Group Con-3 d; Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d) mRNA. However, an improvement in Bcl-2 gene expression (Group SP-3 d vs Group Con-3 d; Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d) was noted in the thymus (p\<0.05). Furthermore, *Bax* gene expression was highest in the piglets provided with 7 h of spermine and lowest for piglets supplied with spermine for 6 d (p\<0.05). The gene expression of caspase-3 decreased with prolonged spermine supplementation of up to 6 d (p\<0.05), and a plateau was observed afterward (p\>0.05). Bcl-2 mRNA level was significantly enhanced with extended spermine administration of up to 6 d, and then a reduction was found thereafter (p\<0.05).

As presented in [Figure 4](#f4-ajas-31-8-1325){ref-type="fig"}, spermine supplementation significantly reduced mRNA expressions of Bax and caspase-3. Conversely, enhanced *Bcl-2* gene expression was observed in the spleen of the piglets (Group SP-6 d relative to Group Con-6 d; Group SP-9 d relative to Group Con-9 d; p\<0.05). In addition, significant down-regulation of *Bax* gene expression was observed with extended spermine intake of up to 6 d, and up-regulation was observed thereafter (p\<0.05). Maximum caspase-3 gene expression for the piglets was obtained at 7 h of spermine ingestion, and the minimum expression was observed after 6 d of spermine administration (p\<0.05). The mRNA expression of Bcl-2 improved with extension of spermine supplementation to up to 6 d, and then decreased afterward (p\<0.05).

Changes of amino acid transporters mRNA levels in the thymus and spleen
-----------------------------------------------------------------------

[Table 3](#t3-ajas-31-8-1325){ref-type="table"} reveals the changes in the amino acid transporters mRNA levels of the thymus. Expressions of amino acid transport-related genes, such as *SLC1A1*, *SLC1A5*, *SLC7A1*, *SLC7A7*, and *SLC15A1*, were significantly increased by spermine supplementation (Group SP-3 d vs Group Con-3 d; Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d; p\<0.05). However, SLC7A9 and SLC6A19 mRNA abundances remained uninfluenced (p\>0.05). Additionally, the mRNA expressions of SLC1A1, SLC1A5, SLC7A1, SLC7A7, and SLC15A1 significantly increased with extended spermine supplementation of up to 6 d before they subsequently decreased (p\<0.05). Extended spermine intake did not affect *SLC7A9* and *SLC6A19* gene expressions (p\>0.05).

Based on the findings shown in [Table 4](#t4-ajas-31-8-1325){ref-type="table"}, spermine supplementation markedly improved the gene expressions of *SLC1A1* and *SLC7A7* (Group SP-6 d relative to Group Con-6 d; Group SP-9 d relative to Group Con-9 d), SLC1A5 (Group SP-3 d vs Group Con-3 d; Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d), SLC7A1 (Group SP-6 d relative to Group Con-6 d), SLC7A9 (Group SP-7 h vs Group Con-7 h; Group SP-3 d vs Group Con-3 d; Group SP-6 d vs Group Con-6 d; Group SP-9 d vs Group Con-9 d), and SLC15A1 (Group SP-9 d relative to Group Con-9 d) (p\<0.05) and did not influence SLC6A19 mRNA level in the spleen of piglets (p\>0.05). Furthermore, SLC1A5, SLC7A7, and SLC7A9 mRNA levels were significantly enhanced with extension of spermine administration to up to 6 d, and their reductions were observed thereafter (p\<0.05). The gene expression of *SLC1A1* was minimum in piglets fed for 7 h with spermine supplementation and maximum at 6 d of spermine administration (p\<0.05). SLC15A1 mRNA abundance was maxinum at 6 d of spermine intake (p\<0.05). No significant differences were obtained for *SLC7A1* and *SLC6A19* gene expressions observed at the four time periods (p\>0.05).

DISCUSSION
==========

Spermine (as one of natural milk components) plays dominating roles in the gut, such as promoting intestinal cell growth and proliferation, alleviating intestinal dysfunction, and regulating intestinal metabolism \[[@b4-ajas-31-8-1325],[@b5-ajas-31-8-1325],[@b14-ajas-31-8-1325]\]. Appropriate dosage of spermine (0.4 mmol/kg BW/24 h) was beneficial to the growth and development of cells according to a previous study \[[@b11-ajas-31-8-1325]\]. Thus, a similar dose was used in this experiment. The thymus and spleen are the crucial central immune organ and the largest peripheral immune organ, respectively, which play important roles in immune reaction and prevention against numerous biological stress responses of the body. Therefore, maintaining the normal functions of immune organs or promoting their development is essential for animal growth and health.

Spermine administration changes expression of cell cycle-related genes in the thymus and spleen
-----------------------------------------------------------------------------------------------

Weaning stress may compromise cells. This effect is closely involved in animal reproduction, growth, and health through damaging DNA and inhibiting cell proliferation. Cell proliferation is relevant to cell cycle. The cell cycle is composed of four phases, including G1, S, G2, and M, and it is regulated by cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors \[[@b15-ajas-31-8-1325]\]. G1 phase plays a crucial role in providing substances and energy for DNA replication during the S phase. Considering the effect of spermine, we assayed G1 phase-related genes, such as p21, cyclin E2, and cyclin D3 in the thymus and spleen. p21, a cyclin-dependent kinase inhibitor, is known as the regulator of the G1/S phase checkpoint and can inhibit cell cycle progression processes by suppressing cell proliferation \[[@b6-ajas-31-8-1325],[@b16-ajas-31-8-1325]\]. Cyclin E2, a novel G1 cyclin, can combine with cyclin-dependent kinase-2 to accelerate the transition of cell from G1 to S phase \[[@b17-ajas-31-8-1325]\]; however, the gene expression of cyclin E2 is rather low in normally proliferating cells and high in diseased cells \[[@b17-ajas-31-8-1325]\]. Additionally, widespread research had been conducted to understand cyclin D3 function. Cyclin D3 is the important regulatory factor for initiating the transition from G1 to S phase, and it is positively associated with tumor progression and formation \[[@b18-ajas-31-8-1325]\]. In the present study, spermine supplementation significantly decreased p21 and cyclin D3 gene expressions in the thymus and spleen. Cyclin E2 mRNA level was markedly reduced in the thymus, whereas it was not significantly affected by spermine intake in the spleen, which may be due to tissue differences in the organs. Further correlation analysis showed that p21 mRNA level was positively correlated with gene expressions of cyclin E2 (*r*~thymus~ = +0.710, *P*~thymus~ = 0.049\*) and cyclin D3 (*r*~spleen~ = +0.806, *P*~spleen~ = 0.016\*), hinting that spermine supplementation promoted cell proliferation through decreased p21 gene expression may be partly due to induced cyclin E2 and cyclin D3 mRNA levels. To further study the effect of spermine ingestion on other phases of the cell cycle, cyclin A2 gene was also evaluated.

In mammalian cell lines, cyclin A2, the main controlling factor of the progress of mitosis, is essential for DNA replication during prophase of mitosis, and the transition of pivotal points, such as the G1--S and G2--M phases, have an important regulating effect on cell cycle \[[@b19-ajas-31-8-1325]\]. Results revealed that a higher level of cyclin A2 gene in both thymus and spleen was observed with spermine administration, and cyclin A2 mRNA expression had substantial relation to p21 gene expression (*r*~spleen~ = −0.912, *P*~spleen~ = 0.002\*\*; *r*~thymus~ = −0.864, *P*~thymus~ = 0.006\*\*) and cyclin D3 mRNA level (*r*~spleen~ = −0.888, *P*~spleen~ = 0.003\*\*; *r*~thymus~ = −0.876, *P*~thymus~ = 0.004\*\*), which implies that spermine administration can effectively modulate cell cycle by interaction of such genes. In addition, prolonged spermine administration also markedly decreased p21 and cyclin D3 mRNA levels in the thymus and spleen, down-regulated cyclin E2 gene expression in the thymus and increased cyclin A2 mRNA expression both in the thymus and spleen, with their minimum/maximum expressions at 6 d after spermine supplementation.

Overall, findings revealed that spermine supplementation can regulate the cell cycle, and such effects were maximized after extended spermine supplementation (6 d). Certainly, further investigation is essential for revealing the detailed mechanism by which spermine administration regulated cell cycle mRNA level. Accumulating evidences have indicated that cell cycle checkpoints appear to link cell cycle to apoptosis. Therefore, we further investigated the effects of spermine supplementation on apoptosis gene expression of thymus and spleen in piglets.

Spermine supplementation alters apoptosis-related gene expressions of the thymus and spleen
-------------------------------------------------------------------------------------------

During normal conditions, apoptosis removes abnormal or damaged cells, maintains the normal function of immune system, and participates in histogenesis during prenatal development, thus adjusting the normal growth of tissues \[[@b18-ajas-31-8-1325],[@b20-ajas-31-8-1325]\]. Previous study indicated that preventing apoptosis can lead to extensive variety of diseases. Nevertheless, uncontrolled apoptosis can be initiated by excessive production of oxidants, which cause pathogenic and damaging effects on organ development \[[@b21-ajas-31-8-1325]\]. Early weaning can cause extensive production of reactive oxygen species and result in oxidative stress, which is implicated in the induction of uncontrolled apoptosis \[[@b21-ajas-31-8-1325]\]. Therefore, the effects of spermine supplementation on apoptosis genes were determined. Bax and caspase-3 are two typical pro-apoptotic genes. Bax is associated with powerful death-promoting capacity, causing the release of cytochrome c and a reduction in the mitochondrial membrane potential \[[@b22-ajas-31-8-1325]\]. Caspase-3 is a member of the cysteine-aspartic acid protease (Caspase) family that can be activated by a variety of signals, including extrinsic and intrinsic pathways, and it becomes active when cleaved by an initiator caspase \[[@b23-ajas-31-8-1325]\]. Following this condition, caspase-3 plays a central role in the execution phase of cell apoptosis \[[@b22-ajas-31-8-1325]\]. A summary of data obtained from this study showed that spermine supplementation significantly down-regulated Bax and caspase-3 mRNA levels in the thymus and spleen of piglets. Further correlation analysis indicated that Bax and caspase-3 gene expression were positively correlated with p21 mRNA level (*r*~Bax-spleen~ = +0.861, *P*~Bax-spleen~ = 0.006\*\*; *r*~caspase-3-spleen~ = +0.874, *P*~caspase-3-spleen~ = 0.005\*\*; *r*~caspase-3-thymus~ = +0.776, *P*~caspase-3-thymus~ = 0.024\*), but negatively associated with cyclin A2 mRNA expression (*r*~Bax-spleen~ = −0.960, *P*~Bax-spleen~ = 0.000\*\*; *r*~Bax-thymus~ = −0.905, *P*~Bax-thymus~ = 0.002\*\*; *r*~caspase-3-spleen~ = −0.961, *P*~caspase-3-spleen~ = 0.000\*\*; *r*~caspase-3-thymus~ = −0.941, *P*~caspase-3-thymus~ = 0.000\*\*), which is consistent with the above-mentioned results that spermine administration enhanced cell proliferation.

Subsequent to this discovery, the relationship between spermine intake and an anti-apoptotic gene was also determined in this study. Bcl-2, an important cell death-regulating gene, is distributed mainly in the outer membrane of the mitochondria and is considered as the major anti-apoptotic gene responsible for preventing cell apoptosis induced by numerous stimuli \[[@b22-ajas-31-8-1325]\]. In this paper, spermine supplementation significantly improved Bcl-2 mRNA level in the thymus and spleen. We also observed that *Bcl-2* gene expression was negatively correlated with Bax mRNA level (*r*~spleen~ = −0.911, *P*~spleen~ = 0.002\*\*; *r*~thymus~ = −0.891, *P*~thymus~ = 0.003\*\*) and caspase-3 mRNA expression (*r*~spleen~ = −0.892, *P*~spleen~ = 0.003\*\*; *r*~thymus~ = −0.924, *P*~thymus~ = 0.001\*\*), which supported the fact that Bcl-2 regulates apoptosis by activating genes in the caspase family \[[@b24-ajas-31-8-1325]\], suggesting that spermine administration increased anti-apoptotic gene expression might be partly attributed to reduced pro-apoptotic gene mRNA levels. Notably, there were no difference in cell apoptosis-related gene expressions of the thymus and spleen when piglets fed with 7 h of spermine intake, which is consistent with the results that spermine supplementation (7 h) did not affect immunity-related gene expressions \[[@b3-ajas-31-8-1325]\]. This effect may be due to spermine taking some time to develop physiological function. Moreover, prolonged spermine supplementation markedly down-regulated gene expression of Bax and caspase-3, and up-regulated Bcl-2 mRNA level both in the thymus and spleen, with optimal effects after 6 d of spermine administration. Together, these observations suggested that spermine supplementation may inhibit cell apoptosis, and a period of 6 d of spermine supplementation exerts such optimal effects.

Changes in the amino acid transporters in the thymus and spleen of piglets with spermine ingestion
--------------------------------------------------------------------------------------------------

It is well-known that the absorption of amino acids rely on the function of their corresponding transporters, and functional defects of these transporters can lead to aminoaciduria or malabsorption. In addition, piglets need abundant nutrients and energy to meet exuberant growth and metabolism, and spermine derives from the precursor for the synthesis of arginine. Considering these facts, in this experiment, alterations in amino acid transporters expression were investigated along with spermine intake. SLC15A1 is the proton oligopeptide cotransporter that provides peptide substrates for intestinal and renal epithelial cells \[[@b25-ajas-31-8-1325]\]. Dietary spermine supplementation markedly increased SLC15A1 mRNA levels in the thymus and spleen which implied that spermine intake may partly promote the growth of immune organs by accelerating oligopeptide synthesis. SLC1A1, as a representative glutamate transporter, can provide the substance and energy required for cellular metabolism through adjusting the cellular absorption of glutamate \[[@b26-ajas-31-8-1325]\]. In this study, spermine administration significantly improved gene expressions of *SLC1A1* in the thymus and spleen of piglets. Further correlation analysis demonstrated that SLC1A1 mRNA level was positively related to cyclin A2 gene expression (*r*~spleen~ = +0.931, *P*~spleen~ = 0.001\*\*; *r*~thymus~ = +0.964, *P*~thymus~ = 0.000\*\*) and negatively associated with p21 mRNA expression (*r*~spleen~ = −0.909, *P*~spleen~ = 0.002\*\*; *r*~thymus~ = −0.814, *P*~thymus~ = 0.014\*), supporting that glutamine has beneficial effects on cell proliferation \[[@b27-ajas-31-8-1325]\].

SLC1A5 and SLC6A19 are two high-affinity amino acid transporters that play important roles in electroneutral exchange of amino acids accompanied by co-transport of sodium \[[@b28-ajas-31-8-1325]\]. Our study discovered that spermine supplementation promoted an increase in the SLC1A5 mRNA level of the thymus and spleen; no such effects were obtained for the *SLC6A19* gene expression, which may be correlated with the tissue differences as described by the previous results observed in the ileum (data not shown).

Additionally, the SLC7 family is usually allocated into two subgroups, the cationic amino acid transporters (e.g., SLC7A1) and glycoprotein-related amino acid transporters (e.g., SLC7A7 and SLC7A9) \[[@b29-ajas-31-8-1325]\]. SLC7A1 aids in transporting cationic amino acid via accelerated diffusion with differential trans-stimulation caused by some intracellular substrates, and it affects the modulation of the rate of nitric oxide synthesis by controlling the uptake of the substrate of nitric oxide synthase (L-arginine) \[[@b30-ajas-31-8-1325]\]. The functions of SLC7A7 and SLC7A9 are diverse due to their substrate selectivity, and they mostly act as obligatory exchangers. They have selective functions in transporting neutral amino acids (system L and asc, Ala, Ser, and Cys-preferring), aromatic amino acids (Tyr, Phe, and Try), and negatively charged amino acids (system x~c~^−^) \[[@b30-ajas-31-8-1325]\]. In the current study, spermine supplementation at a level of 0.4 mmol/kg BW/24 h enhanced the gene expressions of *SLC7A1* and *SLC7A7* in the thymus and spleen, as well as that of SLC7A9 in the spleen. which is similar to the results of a previous study showing that dietary arginine supplementation enhanced ileac SLC7A1 and SLC7A7 mRNA levels \[[@b9-ajas-31-8-1325]\]. In addition, extended spermine supplementation significantly increased *SLC7A7*, *SLC1A1*, *SLC15A1*, and *SLC1A5* gene expressions in the thymus and spleen, SLC7A1 mRNA expression in the thymus and SLC7A9 mRNA abundance in the spleen. Findings suggest that spermine supplementation and its extended duration may modulate amino acid transporters, and such effects were optimal after 6 d of spermine administration. However, the detailed mechanism by which spermine supplementation controlled amino acid transporters gene expression in piglets needs further investigation.

CONCLUSION
==========

The results suggesting that spermine supplementation (0.4 mmol/kg BW/24 h) and its extended duration may modulate cell cycle during the G1/S phase, suppress apoptosis and regulate amino acid transport of the thymus and spleen of piglets in a time-dependent manner, and extended spermine supplementation (6 d) exerts the optimal effects.
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###### 

Composition and nutrient level of the basal formula milk powder (87.5% dry matter basis)

  Items                                                            \%
  ---------------------------------------------------------------- --------
  Ingredients                                                      
   Whole-milk powder (24% crude protein)                           58.00
   Whey protein concentrate (34% crude protein)                    25.00
   Casein                                                          5.70
   Coconut oil                                                     10.00
   CaH~2~PO~4~                                                     0.10
   Choline chloride (50%)                                          0.10
   Vitamin premix[1)](#tfn1-ajas-31-8-1325){ref-type="table-fn"}   0.10
   Mineral premix[2)](#tfn2-ajas-31-8-1325){ref-type="table-fn"}   0.50
   L-arginine (98.5%)                                              0.06
   DL-methionine (98.5%)                                           0.06
   L-lysine·HCl (78.5%)                                            0.30
   L-threonine (98%)                                               0.03
   L-tryptophan (98%)                                              0.05
   Total                                                           100.00
  Nutrient content                                                 
   Digestible energy (kJ/kg)                                       18 390
   Crude protein (%)                                               25.30
   Ca (%)                                                          1.02
   Total phosphorus (%)                                            0.81
   Available phosphorus (%)                                        0.67
   Digestible lysine (%)                                           1.93
   Digestible methionine (%)                                       0.63
   Digestible arginine (%)                                         0.86

Vitamin premix provided per kg powder diet: vitamin A, 0.94 mg; vitamin D~3~, 0.01 mg; vitamin E, 20 mg; vitamin K~3~, 1 mg; vitamin B~12~, 0.04 mg; riboflavin, 5 mg; niacin, 20 mg; pantothenic acid, 15 mg; folic acid, 1.5 mg; thiamin, 1.5 mg; pyridoxine, 2 mg; biotin, 0.1 mg.

Mineral premix provided per kg powder diet: Zn, 90 mg; Mn, 4.0 mg; Fe, 90 mg; Cu, 6.0 mg; I, 0.2 mg; Se, 0.3 mg.

###### 

Primer sequences of the target and reference genes of the thymus and spleen in piglets

  Genes         Primer sequence (5′-3′)   Product (bp)                Annealing temperature (°C)   GenBank accession   
  ------------- ------------------------- --------------------------- ---------------------------- ------------------- ----------------
  *β-Actin*     Forward:                  TGCGGGACATCAAGGAGAA         58                           58                  DQ452569.1
                Reverse:                  GCCATCTCCTGCTCGAAGTC                                                         
  *p21*         Forward:                  ACCCTCCTGGCCCTTGAC          60                           58                  XM_001929558.3
                Reverse:                  TTTGCTACAGGGCCCTACTTTC                                                       
  *Cyclin D3*   Forward:                  TCCAAGCTGCGCGAGACTA         64                           58                  DQ915494.1
                Reverse:                  CAGAGTGGTCCGTGTAGATGCA                                                       
  *Cyclin E2*   Forward:                  CACCACCCAAGAGCACAGAAA       67                           58                  NM_001243931.1
                Reverse:                  CCAACCTGTTTGCTCAGTTAACTTC                                                    
  *Cyclin A2*   Forward:                  TCGATGTCTGTGTTGAGAGGAAA     64                           58                  NM_001177926.1
                Reverse:                  TTGAGGCCAACAGCATAGCA                                                         
  *Bax*         Forward:                  GCCTCAGTGTTCTTGTCTTTGGT     59                           58                  AM233489.1
                Reverse:                  TCGGGCAACGTGTGGAA                                                            
  *Caspase-3*   Forward:                  CCGGAATGGCATGTCGAT          60                           58                  NM_214131.1
                Reverse:                  TGAAGGTCTCCCTGAGATTTGC                                                       
  *Bcl-2*       Forward:                  CCAGCATGCGGCCTCTAT          57                           58                  AB271960.1
                Reverse:                  GACTGAGCAGCGCCTTCAG                                                          
  *SLC1A1*      Forward:                  TTCTTTGTTCCCCACATCTTTCTT    68                           58                  NM_001164649.1
                Reverse:                  CCCTTCCCACACTCGACTGA                                                         
  *SLC1A5*      Forward:                  CCCTTCCCACACTCGACTGA        57                           58                  XM_003127238.4
                Reverse:                  CCCGGACCTAGCCTCTTGA                                                          
  *SLC7A1*      Forward:                  CATCTTTGCCGTGATCATAATTCT    79                           58                  NM_001012613.1
                Reverse:                  TTTGTTGACCATGGCTGACTCT                                                       
  *SLC7A7*      Forward:                  TTTGGTTCCCAAGGTTGCA         58                           58                  NM_001110421.1
                Reverse:                  GCAGCTTCCTGGCATTGC                                                           
  *SLC7A9*      Forward:                  TTGCCATCATCTGTCTCAGCTT      62                           58                  EF127857.1
                Reverse:                  GCTGCAGCCTGCGTAGAAG                                                          
  *SLC6A19*     Forward:                  GCAACGTGACGCAGGAGAA         57                           58                  XM_003359855.3
                Reverse:                  GGTCGGAGGCGTTGCA                                                             
  *SLC15A1*     Forward:                  GCTGCAGCCTGCGTAGAAG         61                           58                  NM_214347.1
                Reverse:                  ACTGCAAGCAACGACCATGA                                                         

p21, cyclin A2, cyclin D3 and cyclin E2, cell cycle related factor; Bax and Bcl-2, apoptosis related factor; Caspase-3, cysteine-aspartic acid protease factor 3; SLC, amino acid transport related factor.

###### 

Effects of spermine supplementation on amino acid transporters mRNA levels in the thymus of piglets

  Items     Treatment time                                       SEM                                                  p-value                                                                                                                                                                                                                                                                                                                                                 
  --------- ---------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------- ------ ------- ------- -------
  SLC1A1    1.00[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.19[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.40[ab](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   2.39[d](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   2.32[cd](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   4.34[f](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.83[bc](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   3.11[e](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   0.17   0.000   0.000   0.000
  SLC1A5    1.00[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.38[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.45[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    2.18[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   2.28[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    4.28[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   2.03[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    2.73[c](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   0.14   0.000   0.000   0.000
  SLC7A1    1.00[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.27[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.41[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    2.31[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   3.00[c](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    4.73[d](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   2.10[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    3.26[c](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   0.18   0.000   0.000   0.000
  SLC7A7    1.00[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.28[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.13[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    2.09[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   2.09[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    5.46[d](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.94[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    3.36[c](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   0.21   0.000   0.000   0.000
  SLC7A9    1.00                                                 1.05                                                 1.06                                                  0.94                                                 1.03                                                  1.12                                                 0.98                                                  1.11                                                 0.03   0.496   0.803   0.423
  SLC6A19   1.00                                                 1.03                                                 1.09                                                  1.10                                                 1.03                                                  1.08                                                 0.98                                                  1.13                                                 0.03   0.370   0.827   0.886
  SLC15A1   1.00[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.32[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.24[a](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    1.98[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   1.96[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    3.52[d](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   2.03[b](#tfn6-ajas-31-8-1325){ref-type="table-fn"}    2.74[c](#tfn6-ajas-31-8-1325){ref-type="table-fn"}   0.13   0.000   0.000   0.004

SEM, standard error of the mean; Con, control diet; SP, spermine-supplemented diet.

Values are means±SEM (n = 6).

Means in the same row bearing different superscripts differ significantly.

###### 

Effects of spermine administration on amino acid transporters mRNA expressions in the spleen of piglets

  Items     Treatment time                                        SEM                                                    p-value                                                                                                                                                                                                                                                                                                                                                      
  --------- ----------------------------------------------------- ------------------------------------------------------ ----------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ------ ------- ------- -------
  SLC1A1    1.00[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.08[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}     0.97[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.23[ab](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.47[bc](#tfn9-ajas-31-8-1325){ref-type="table-fn"}     2.66[d](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.09[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.81[c](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    0.09   0.000   0.000   0.000
  SLC1A5    1.00[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.32[ab](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.30[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.82[bc](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    2.04[c](#tfn9-ajas-31-8-1325){ref-type="table-fn"}      3.76[e](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.50[ab](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   2.72[d](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    0.14   0.000   0.000   0.001
  SLC7A1    1.00[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.16[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}     1.11[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.14[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}     1.09[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}      1.39[b](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.04[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.17[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    0.04   0.018   0.129   0.349
  SLC7A7    1.00[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.19[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}     1.34[ab](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.75[bc](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    2.09[c](#tfn9-ajas-31-8-1325){ref-type="table-fn"}      3.86[e](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.71[bc](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   2.54[d](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    0.14   0.000   0.000   0.000
  SLC7A9    1.00[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.38[b](#tfn9-ajas-31-8-1325){ref-type="table-fn"}     1.33[ab](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.87[c](#tfn9-ajas-31-8-1325){ref-type="table-fn"}     1.86[c](#tfn9-ajas-31-8-1325){ref-type="table-fn"}      3.39[e](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.57[bc](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   2.30[d](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    0.11   0.000   0.000   0.000
  SLC6A19   1.00                                                  1.01                                                   0.94                                                  0.99                                                   1.17                                                    1.13                                                 0.94                                                  1.12                                                  0.03   0.356   0.127   0.526
  SLC15A1   1.00[ab](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.06[abc](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   0.99[ab](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.32[bcd](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.25[abcd](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   1.58[d](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   0.94[a](#tfn9-ajas-31-8-1325){ref-type="table-fn"}    1.39[cd](#tfn9-ajas-31-8-1325){ref-type="table-fn"}   0.05   0.001   0.018   0.405

SEM, standard error of the mean; Con, control diet; SP, spermine-supplemented diet.

Values are means±SEM (n = 6).

Means in the same row bearing different superscripts differ significantly.
